Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Recipharm, Synthonics in Drug Delivery Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Recipharm, Synthonics in Drug Delivery Pact

To offer metal coordination chemistry to improve delivery and absorption

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Recipharm Pharmaceutical Development and Synthonics, Inc. have entered a joint promotion agreement to provide Recipharm customers full access to Synthonics’ metal coordination chemistry to improve the delivery and performance of compounds.
 
Recipharm PD’s general manager, Maria Lundberg, said, “We are pleased to partner with Synthonics to expand the services and solutions that we can offer our clients. The application of Synthonics’ chemistry improves important characteristics such as bioavailability and solubility and thus increases the likelihood that promising molecules will become viable products. Furthermore, our ability to offer such services through this novel partnership distinguishes us from other CDMOs.”
 
Ken Slepicka, chief executive officer of Synthonics, said, “Synthonics is delighted to partner with Recipharm to help advance promising molecules to market. We are very impressed with Recipharm’s formulation and development teams and believe that our chemistry will fit well in their existing tool kit of solutions. We expect this agreement to help us reach new clients and to expand the use of our chemistry.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics